eli lilly retatrutide Lilly's hits Phase III goals with FDA filing planned for 2027 Retatrutide is Eli Lilly’s “Triple

Mechanism of action DNF-10: decreasing food intake It has been demonstrated that there is a significant impact on the modulators of short-term food intake at both the hypothalamic level (NPY) and the digestive level, resulting in a decrease in the hunger hormone ghrelin

10.1016/j.canlet.2004.05.004 Cancer Lett

Beyond helping you lose weight and keep your blood sugar under control, these drugs have also been shown to improve your blood pressure and cholesterol numbers and lower your heart disease risk

Seek immediate medical help if these occur

Berberine and other ingredients may enter breast milk with unknown effects on infant development and growth

Both are antioxidants